Search for: "King v. King et al" Results 421 - 440 of 561
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Feb 2010, 1:17 pm by Lyle Denniston
Tuesday, the Supreme Court will hear one hour of oral argument in McDonald, et al., v. [read post]
8 Feb 2010, 4:02 am
Boston Scientific (Docket Report)(271 Patent Blog) District Court N D Illinois: Allegation that plaintiff ‘buried’ prior art in IDS is sufficient to state of claim for inequitable conduct: CIVIX-DDI LLC v National Association of Realtors et al (Docket Report) District Court Massachusetts: Attorney delinquence excuses 7 year delay in reviving expired patent: SprinGuard Technology Group Inc. v USPTO (271 Patent Blog) District Court Wyoming: Filing a… [read post]
1 Feb 2010, 3:04 am by Omar Ha-Redeye
Eugene Volokh discusses religious exemptions of a different type, from mandatory autopsies for executed killers in Johnson v. [read post]
1 Jan 2010, 2:00 am
(IPKat)   United States US General November and December 2009 – quick links of all the top stories (Technology & Marketing Law Blog) (Technology & Marketing Law Blog)   US Patents If nothing else, patent attorneys will follow the semantics – machine-or-transformation standard and claim terms (ISinIP)   US Patents – Lawsuits and strategic steps Nokia - Nokia hurls new salvo in spat with Apple, complains to ITC (Ars Technica) (ITC)   US Copyright US… [read post]
30 Nov 2009, 5:12 am
Bettauer United States Court of Appeals for the 11th Circuit: King et al. v. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs)   Products Ablify (Aripiprazole) – US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) – US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) – US: Teva files amended complaint against Momenta/Sandoz to include infringement of three… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
13 Oct 2009, 12:16 pm
” Dissenting alone as the Court denied review in Sorich, et al., v. [read post]
25 Sep 2009, 6:13 am
King et al. which put a decision on hold until the Supreme Court makes a determination in three similar cases: National Rifle Association v. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
8 Sep 2009, 9:58 am
References: Abu Dhabi Commercial Bank, et al. v. [read post]